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Sotos syndrome, characterized by intellectual dis-
ability and characteristic facial features, is caused
by haploinsufficiency in theNSD1 gene.We conduct-
ed an etiological study on two siblings with Sotos
features without mutations in NSD1 and detected a
homozygous frameshift mutation in the APC2 gene
by whole-exome sequencing, which resulted in the
loss of function of cytoskeletal regulation in neurons.
Apc2-deficient (Apc2/) mice exhibited impaired
learning andmemory abilities alongwith an abnormal
head shape. Endogenous Apc2 expression was
downregulated by the knockdown of Nsd1, indi-
cating that APC2 is a downstream effector of NSD1
in neurons. Nsd1 knockdown in embryonic mouse
brains impaired the migration and laminar posi-
tioning of cortical neurons, as observed in Apc2/
mice, and this defect was rescued by the forced
expression of Apc2. Thus, APC2 is a crucial target
of NSD1, which provides an explanation for the intel-
lectual disability associated with Sotos syndrome.
INTRODUCTION
Overgrowth syndromes are a heterogeneous group of disorders
defined by the generalized or localized excess growth of a body
part (Visser et al., 2009). One prominent overgrowth syndrome is
Sotos syndrome (OMIM #117550; also known as cerebral gigan-
tism, with an estimated incidence of 1/14,000 live births), which
is characterized by varying degrees of mental retardation and a
combination of typical facial features (i.e., a prominent forehead
with a receding hairline, downslanting palpebral fissures, and aCellpointed chin) and large head circumference (Cole and Hughes,
1994; Sotos et al., 1964; Tatton-Brown et al., 2012). Additional
features may include hypotonia, advanced bone age, seizures,
prognathia, cardiac and renal anomalies, and scoliosis. The
NSD1 (Nuclear receptor-binding Set Domain containing 1)
gene, which encodes a histone methyltransferase that has
been implicated in transcriptional regulation, was previously
reported to be deleted or mutated in 90% of Sotos syndrome
cases (Baujat and Cormier-Daire, 2007; Douglas et al., 2003;
Kurotaki et al., 2002). NSD1 is considered to regulate the expres-
sion of a battery of genes required for the normal development of
several tissues; however, the downstream effector molecules
encoded by these genes and the mechanisms that cause indi-
vidual Sotos features currently remain unknown.
We recently demonstrated that APC2 (Adenomatous polypo-
sis coli 2), an APC-like protein, is crucially involved in brain devel-
opment through its regulation of neuronal migration and axon
guidance (Shintani et al., 2009, 2012). APC is a microtubule
plus-end tracking protein (+TIP) and is also known as a tumor
suppressor (Midgley et al., 1997; Mimori-Kiyosue et al., 2000).
APC is broadly expressed in most mammalian tissues (Midgley
et al., 1997), whereas APC2 is preferentially expressed in postmi-
totic neurons throughout development (Shintani et al., 2009,
2012). APC2 has been shown to co-localize with and stabilize
microtubules (Shintani et al., 2009). It is also distributed along
actin fibers and influences their dynamics by regulating the acti-
vation of Rho family GTPases (Shintani et al., 2012). Severe
layering defects were detected in some brain regions of Apc2-
deficient (Apc2/) mice due to dysregulated neuronal migration,
and Apc2/ neurons were shown to be defective in directional
migration in response to extracellular guidance molecules
in vitro (Shintani et al., 2012). APC2 also plays a role in axonal
path-finding by regulating the responsiveness of axonal growth
cones to guidance molecules (Shintani et al., 2009). Therefore,
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regulation in neurons in response to endogenous extracellular
signals. We previously speculated that loss of APC2 function
may be involved in the etiology of human genetic neurological
disorders (Shintani et al., 2012).
Here, we performed an etiological study on two siblings with
Sotos-like overgrowth features: intellectual disability and relative
macrocephaly with a long face and prominent chin and nose.
Whole-exome sequencing (WES) of these patients revealed a
homozygous frameshift mutation in the APC2 gene, but no
mutations in NSD1 or other known susceptibility genes. Cell-
based functional assays indicated that themutant APC2 of these
patients was a functionally null protein. Apc2/ mice exhibited
significantly impaired learning and memory abilities together
with an abnormal brain structure and head shape, indicating a
high degree of concordance between the phenotypes observed
in human patients and knockout mice. Expression of APC2
was also revealed to be under the control of NSD1. Impaired
migration of cortical neurons was observed when Nsd1 was
knocked down in the embryonic brain, as in the Apc2/ brain,
and this defect was rescued by the forced expression of
Apc2. The results of the present study provide a detailed mech-
anism for the intellectual disability associated with Sotos
syndrome.
RESULTS
Patients with Sotos-Syndrome-like Features
The patients’ parents were healthy first cousins of Egyptian
descent and only had two affected children: a girl (patient 1,
aged 10 years) and boy (patient 2, aged 8 years). Both affected
siblings were born at term after an uneventful pregnancy, and
early development was within normal limits. However, they
both had a severe receptive and expressive language disorder
and learning difficulties as well as hyperactive behavior. Their in-
telligence quotients were 60 and 56 for the girl and boy, respec-
tively. The girl had an occipital frontal circumference (OFC)
of 53 cm (the 98th percentile), weight of 20.4 kg, and height of
117 cm (both in the 25th percentile) at 7 years (89 months) of
age, and the boy had an OFC of 50 cm (in the 98th percentile),
weight of 23.3 kg (50th percentile), and height of 120 cm (90th
percentile) at 5 years (64 months) of age. Sotos syndrome was
suspected based on the intellectual disability and physical find-
ings of relative macrocephaly with a long face and prominent
chin and nose (Figure 1A). These patients did not have any other
disorders such as advanced bone age, hypotonia, seizures, or
an autistic phenotype.
A Homozygous Frameshift Mutation in the APC2 Gene
In view of the parents’ consanguinity, the most likely mode of in-
heritance in this family was considered to be autosomal reces-
sive. Array-based comparative genomic hybridization identified
no copy-number changes in any known genes relevant to the
clinical features of our patients (data not shown). We subse-
quently performed WES on the genomic DNA of the two
patients as described previously (Fahiminiya et al., 2014;
McDonald-McGinn et al., 2013). We did not detect any rare
sequence variations within the reported genes associated with
Sotos syndrome (NSD1) or other overgrowth syndromes1586 Cell Reports 10, 1585–1598, March 10, 2015 ª2015 The Author(NFIX, EZH2, PTEN, DNMT3A, and SETD2). However, a
homozygous single-nucleotide duplication of C was detected
in exon 15 (c.5199 dup) of the APC2 gene (NM_005883) in
both patients, which was located within a 3.2-Mb overlapping
region of homozygosity (Figures 1B and 1C; Table S1). This
duplication resulted in a frameshift in the open reading frame
(ORF) of the APC2 gene, in which 570 amino acid residues in
the C terminus were replaced with 418 aberrant residues
(p.[Lys1734Glnfs*418]). Subsequent sequencing analyses re-
vealed that their parents were heterozygous for the APC2
mutation, consistent with an autosomal-recessive mode of
inheritance (Figure 1C).
The Mutant APC2 Protein Is Functionally Null
To identify functional alterations in the mutated APC2 protein
encoded by the patients’ genomes at the cellular level, we con-
structed three humanAPC2 constructs:WT hAPC2,Mut hAPC2,
andDC hAPC2 (Figure 2A). We expressed them in Neuro2a cells
that were endogenously devoid of detectable levels of APC2
proteins (Figure S1). Neuro2a is generally used to study cytoskel-
etal regulation in neurons. N-terminally tagged wild-type (WT)
and mutant APC2 proteins were expressed with the expected
molecular sizes in Neuro2a cells (Figure S2A). We first verified
that N-terminal tagging did not alter the subcellular distribution
or microtubule-stabilizing activities of WT hAPC2 (Figure S2).
As expected, the WT hAPC2 proteins were co-localized with mi-
crotubules (Figure S2B). We then estimated microtubule stabili-
zation activities by using the microtubule-destabilizing agent
nocodazole. The WT hAPC2 exhibited the ability to stabilize
microtubules (Figure S2C), as previously reported for WT APC2
proteins with or without C-terminal tags (Shintani et al., 2009,
2012). Of note, neither of the APC2 mutant proteins (Mut
hAPC2 and DC hAPC2) was distributed along the microtubules
(Figure 2B), and they exhibited a large punctate pattern (see
below). Furthermore, when we estimated the amount of acety-
lated tubulins (the stabilized form of microtubules), we found
that the two APC2 mutants had lost the microtubule stabilization
activities of WT APC2 (Figure 2C).
APC2 has been shown to co-localize with F-actin and stimu-
late the activity of the Rho family GTPase, Rac1 (Shintani et al.,
2012). TheWT hAPC2 was co-localized with F-actins in Neuro2a
cells, whereas the APC2 mutants were not (Figure 3A). The
amount of active Rac1 was 1.4-fold higher in WT hAPC2-
expressing cells than in mCherry-expressing control cells
(Figure 3B), as previously reported (Shintani et al., 2012). In
contrast, the expression of Mut hAPC2 or DC hAPC2 did not
significantly upregulate the level of active Rac1 (Figure 3B), indi-
cating that both mutants were defective for increasing the activ-
ity of Rac1. It should be noted that Mut hAPC2 and DC hAPC2
had no dominant-negative activities on the WT hAPC2 protein
(Figure S3).
The mislocalization of mutant APC2 proteins was also exam-
ined in cortical neurons derived from Apc2/ mice, which may
reflect more in vivo conditions than Neuro2a. In primary cultured
cortical neurons, WT hAPC2 proteins were distributed along
microtubules throughout the neurites, growth cones, and cell
bodies, whereas both of the mutant forms (Mut hAPC2 and DC
hAPC2) were prominently concentrated in the cell bodiess
Figure 1. Identification of a Homozygous
Single-Nucleotide Duplication in the APC2
Gene by WES and Sanger Sequencing
(A) Pedigree of the consanguineous Egyptian
family. The healthy parents (open symbols) and
two affected children (closed symbols) are shown.
The father had three children from a previous
marriage: healthy twin boys and a girl who died
due to congenital heart disease. Specific consent
to publish facial photographs was obtained from
the parents.
(B) A plot of the B allele frequency (BAF) on chro-
mosome 19. The x axis shows the positions of the
variants on chromosome 19 and the y axis is BAF.
Values of 0.5 for each position indicate a het-
erozygote and a value of 1 indicates a homozygote
for the B allele. The 3.2 MB region of homozy-
gosity surrounding APC2 is indicated by red dots.
The genomic position of the APC2 variant is
chr19:1468499.
(C) Electropherograms of the unaffected parents
with a heterozygous mutation and the patients
with a homozygous mutation. Both patients
carried the homozygous one-base duplication
(NM_005883: c.5199 dup), producing mutant
APC2 proteins in which 750 amino acid residues in
the C terminus were replaced with 418 aberrant
residues (p.[Lys1734Glnfs*418]). The WT and
mutated DNA sequences are shown at the top
and bottom of the figure along with the encoded
amino acid sequences. Sanger sequencing was
performed for the reverse strand. Asterisks show
overlapping of differentWT andmutant sequences
because of a single nucleotide shift by a hetero-
zygous one-base duplication of C.
See also Table S1.(Figures 3C and 3D), suggesting that the C-terminal region (570
amino acids) of WT hAPC2 was indispensable for its proper dis-
tribution in endogenous neurons. Unlike the case with Neuro2a
cells (see above, Figure 2B), no characteristic punctate (vesicu-
lar) signals were observed in primary cultured cortical neurons
(Figure 3D). Therefore, the punctate distribution of Mut APC2 in
Neuro2a presumably has no physiological relevance in vivo.
Notably, the Mut APC2 proteins in Neuro2a were partiallyCell Reports 10, 1585–1598co-localized with the lysosome marker
LAMP2 or the autophagy-related marker
LC3 (Figures S4A and S4B).
Using a series of deletion mutations,
we identified an amino acid region
(1821–1900, named region S) that was
required for proper distribution along the
microtubules as well as their stabilization
(Figures S5A and S5B). The loss of func-
tion of DC hAPC2 was restored by the
fusion of region S at the C terminus
of DC in cultured cells (Figures S5C
and S5D). Based on these results, we
concluded that both Mut hAPC2 and DC
hAPC2 lacking region S were loss-of-
function mutants, and that the mutationin the APC2 gene was the probable cause of the clinical pheno-
types of the patients.
Apc2-Deficient Mice Recapitulate Brain Features
of Sotos Syndrome
We determined whether the Apc2/ mouse (Shintani et al.,
2012) recapitulated the phenotypes of the patients. One charac-
teristic feature of both patients (and Sotos syndrome patients), March 10, 2015 ª2015 The Authors 1587
Figure 2. Subcellular Distribution of WT and Mutant APC2 Proteins in Primary Cortical Neurons and Neuro2a Cells
(A) Schematic representation of the structures of the WT and mutant APC2 proteins constructed in this work. APC2 harbored N-terminal coiled-coil domains, a
conserved region, armadillo repeats, 20 amino acid repeats, and SAMP repeats.Mut hAPC2 contained a single nucleotide duplication of C at nucleotide 5199, as
in the patients. This duplication yielded a frameshift of 418 amino acids at the C-terminal portion of the APC2 protein, followed by a premature stop codon
(indicated by a red line). DC hAPC2 was identified as a carboxy-truncated APC2 mutant at Pro-1733. To examine the subcellular distribution of the proteins, all
constructs were designed as N-terminal mCherry fusion proteins.
(B) Distribution of APC2proteins inNeuro2a cells using a confocal laser scanningmicroscope.WT APC2 proteins (red) were distributed alongmicrotubules (green). In
contrast, both of the mutant APC2 proteins showed granular stainings (red), which were not co-localized with microtubules (green). Scale bars represent 5 mm.
(C) Left: immunostaining of acetylated tubulin (green) in transfected Neuro2a cells. Right: changes in the signal intensity of acetylated tubulins (Ac-tubulin) by
APC2mutants. An increase in Ac-tubulin was observed inWT APC2-expressing cells, and acetylated tubulin was protected against the nocodazole treatment. In
contrast, neither of the mutant APC2 proteins exhibited a microtubule-stabilizing effect. Mean ± SE for 40 cells. **p < 0.01, significant difference between the
indicated pairs (ANOVA followed by Scheffe’s post hoc test). Scale bars represent 10 mm.
See also Figures S1–S5.
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Figure 3. Functional Analyses of Human Mutant APC2 Proteins
(A) Distribution of APC2 proteins in Neuro2a cells using TIRFM.WT APC2 proteins (red) were revealed to be distributed along F-actins (green). In contrast, both of
the mutant APC2 proteins showed granular stainings (red), which were not co-localized with F-actins (green). Scale bars represent 5 mm.
(B) GTP-bound Rac1 and total Rac1 levels in transfected Neuro2a cells. Rac1 activation was induced byWT APC2, but not by the mutant proteins. Mean ± SE for
four experiments (right). *p < 0.05, significant difference between the indicated pairs (ANOVA followed by Scheffe’s post hoc test).
(C) Subcellular distribution of APC2 proteins in primary cortical neurons. Small panels show enlarged views of growth cones (top) and cell bodies (bottom) in the
large mCherry panels. WT hAPC2 proteins were detected in the neurites and growth cones, in addition to the cell bodies. In contrast, both of the APC2 mutants
were detected preferentially in the cell bodies, but only scarcely in the neurites and growth cones. Neurons from the Apc2-deficient mouse at P0 were used for
exogenous expression. gc, growth cone; s, soma. Scale bars represent 10 mm.
(D) Expanded imagesof the cell bodyof cortical neurons.Mut hAPC2proteinswere selectively distributed in the somaof cortical neurons. Scale bars represent 10mm.
See also Figures S2, S3, and S5.
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was a large head circumference (Cole and Hughes, 1994; Sotos
et al., 1964; Tatton-Brown et al., 2012). Micro-computed tomog-
raphy (micro-CT) imaging of live mice revealed that Apc2/
mice had an abnormal head shape (Figure S6): the skull length
was shortened without a change in the skull height (i.e., the ratio
of the skull height to length was increased), whereas the ratio of
the skull circumference to body length was increased. However,
the body length was shortened, as described in our previous
study (Shintani et al., 2012). These CT appearances appeared
to resemble the large head and head circumference of our
patients.
MRI studies have revealed that patients with Sotos syndrome
often have dilated ventricles in the brain (Cecconi et al., 2005;
Schaefer et al., 1997). We observed prominent lateral ventricles
in the brain of the male patient by MRI (Figure 4A). T2-weighted
axial sections showed dilation in both lateral ventricles, which
was particularly prominent in the right ventricle (Figure 4A, left).
T1-weighted axial and T2-weighted coronal sections confirmed
ventricular dilation with a prominent trigone region (Figure 4A,
middle and right, respectively). These results further supported
the diagnosis of Sotos syndrome in our patients.
CT imaging of the heads ofApc2/mice stainedwith contrast
material revealed that the brains also had dilated ventricles,
similar to what was observed in our patients (and Sotos syn-
drome patients) (Figure 4B). The ventricles of Apc2/ mice
were significantly larger than those of WT and Apc2+/ mice
(1.8-fold larger; Figure 4B), though marked variations in the
size of the ventricles were observed among Apc2/ mice.
Agenesis or hypoplasia of the corpus callosum has occasionally
been observed in Sotos syndrome patients (Cecconi et al., 2005;
Schaefer et al., 1997). The thickness of the corpus callosum was
significantly reduced in Apc2/ mice (75% that of WT mice;
Figure 4C). However, our male patient did not have marked de-
fects in the corpus callosum (data not shown).
Behavioral Abnormalities in Apc2-Deficient Mice
We conducted a series of behavioral tests on Apc2-deficient
mice to determine whether they exhibited any intellectual or
behavioral defects. In the open-field test, horizontal locomotion
(number of crossings) in the total area was decreased by
repeated exposure to the test environment in all genotypes (Fig-
ure 5A). However, the frequency with which Apc2+/ and
Apc2/ mice entered the central area was significantly lower
than that observed for WT mice during the first open-field expo-
sure (Figure 5B). No other significant differences were observedFigure 4. Abnormal Brain Structures of the Male Patient and Apc2-Defi
(A) Brain MRI images of the male patient. T2-weighted axial (left), T1-weighted a
ventricles. Arrows and arrowheads indicate the lateral ventricles and trigone reg
(B) Coronal CT images of the heads of Apc2+/+, Apc2+/, and Apc2/ mice. Hea
indicate the lateral and third ventricles, respectively. Two representative coron
represent 1 mm. Ventricle volumes were expressed as a percentage relative to th
individual mouse (open, Apc2+/+; hatched, Apc2+/; closed, Apc2/; n = 5 for eac
test). Note: marked variations were observed in the whole ventricular volume amon
(C) MBP staining of brain sections from Apc2+/+, Apc2+/, and Apc2/mice. Th
squares in the upper images. Two representative images of the coronal sections
plot (bottom), each circle corresponds to an individual mouse (open, Apc2+/+; ha
shows the mean value. **p < 0.001 (Student’s t test). See also Figure S6.
Cellin the general behavior of Apc2-deficient mice, including explor-
atory rearing (Figure 5C). We then performed a novel-object
exploration test using the same open field, to which the mice
were already well habituated. The exploratory activity ofApc2/
mice toward the novel object on day 1 was significantly higher
than that of WT mice, and these high activity levels were main-
tained on day 2 (Figures 5D and 5E).
Apc2/ mice also exhibited enhanced exploratory activity in
the elevated-plus maze test (Figure 5F). Since no genotypic dif-
ference was observed in the time spent in the open arms (Fig-
ure 5G), the increase in exploratory activity was not associated
with a reduction in fear or anxiety toward the aversive environ-
ment. In a social-behavior test, Apc2/ mice showed a signifi-
cantly increased duration of interaction with the social target
(an unfamiliar mouse), but also an increased interaction with an
inanimate cage (Figure 5H). Therefore, no significant difference
was observed in social versus inanimate preferences among ge-
notypes (Figure 5I), which suggested that the deficiency in Apc2
did not affect social interactions, but rather solely increased
spontaneous exploratory activity. Thus, the non-autistic behav-
ioral abnormalities observed in Apc2-deficient mice also resem-
bled the clinical features of our patients.
Learning Disability in Apc2-Deficient Mice
We conducted a Morris water-maze analysis to evaluate spatial
learning and memory abilities. All genotypes showed similar
escape latencies in the visible-platform test (Figure 6A), which
indicated that the motor (swim) and sensory (vision) functions
of Apc2-deficient mice were normal. However, Apc2/ mice
clearly exhibited impaired learning abilities in the hidden-plat-
form test and did not reach the criterion of learning in a total of
42 trials. Approximately 20 trials were sufficient for normal
mice (Figure 6B). After the mice completed the hidden-platform
task, we performed a probe test by removing the platform from
the swimming pool. Apc2/ mice showed a preference for the
target quadrant, similarly to WT mice (Figure 6C), but performed
a significantly lower number of crossings than WT mice (Fig-
ure 6D). Heatmap analyses of occupancy times clearly indicated
that the Apc2/ mice did not learn the platform location accu-
rately (Figure 6E), and there were no genotypic differences in
swim speed (Figure 6F). These results indicated that Apc2-defi-
cient mice had impaired learning-memory function.
Apc2/ mice consistently showed impaired learning and
memory abilities in the conditioned-fear test, in which mice
learned to avoid entering a dark compartment in a light/darkcient Mice
xial (middle), and T2-weighted coronal (right) sections showing dilated lateral
ion, respectively.
ds were stained with contrast material and scanned. Arrows and arrowheads
al images of the brains of Apc2/ mice (#1 and #2) are shown. Scale bars
e total brain volume. In the scatter plot (bottom), each circle corresponds to an
h group), and the horizontal bar shows the mean value. **p < 0.001 (Student’s t
gApc2/mice, but the average value was significantly higher than that ofWT.
e lower images show enlargements in the corpus callosum region enclosed by
of Apc2-deficient mice (#1 and #2) are shown. Scale bars, 1 mm. In the scatter
tched, Apc2+/; closed, Apc2/; n = 5 for each group), and the horizontal bar
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Figure 5. Increased Exploratory Behavior of Apc2-Deficient Mice
(A–C) Increased center region activity in Apc2-deficient mice in the open field. Mice were exposed to the open field for 5 min per day on 3 consecutive days and
their behaviors were observed. Horizontal locomotor activity in the total area (A), rate of locomotor activity in the center area (B), and rearing activity (C) were
quantified and analyzed. Apc2+/+ (n = 11), Apc2+/ (n = 12), and Apc2/ (n = 11). Data are the mean ± SE. *p < 0.05, significantly different from WT mice on the
same day (Tukey-Kramer test).
(D and E) Increased exploratory activity in a novel-object test. This test was repeated using the same object on 3 consecutive days. Exploratory activity toward the
object was estimated by the number of times the center circle line was crossed. Exploratory activity in the absence () or presence (+) of the object (D) and
horizontal locomotor activity in the peripheral area (E) were quantified. Apc2+/+ (n = 11), Apc2+/ (n = 12), and Apc2/ (n = 11). Data are the mean ± SE. *p < 0.05,
**p < 0.01; significantly different from time-matched WT mice (ANOVA followed by Scheffe’s post hoc test).
(F and G) Normal anxiety level of Apc2-deficient mice in an elevated-maze test. The number of entries into the open or closed arms (F) and time spent in the open
arms in the elevated plus maze (G) were quantified and analyzed. Apc2+/+ (n = 11), Apc2+/ (n = 12), and Apc2/ (n = 11). Data are the mean ± SE. *p < 0.05,
significantly different from WT mice (Tukey-Kramer test).
(H and I) Normal social-interaction behaviors of Apc2-deficient mice. Interaction activity was determined by the time spent in the center area. Time spent in-
teracting with an empty cage (novel inanimate) and an unfamiliar immobilized target mouse (social) (H), and the ratio of social to novel inanimate activity (I) are
summarized. Data are the mean ± SE. Apc2+/+ (n = 14), Apc2+/ (n = 15), and Apc2/ (n = 15). *p < 0.05, significantly different fromWTmice (Tukey-Kramer test).avoidance apparatus after receiving one session of footshocks in
the dark compartment (Figure 6G). Thus, we observed a high de-
gree of concordance between our patients and these knockout
mice with regard to brain dysfunction.
Apc2 Is a Downstream Target of Nsd1
NSD1 has been identified as the primary gene responsible for
Sotos syndrome. It acts as a transcriptional regulator that1592 Cell Reports 10, 1585–1598, March 10, 2015 ª2015 The Authormodifies the expression of downstream genes that are more
directly involved in the normal growth and development of
several tissues, including the brain. We speculated that APC2,
which is involved in brain development, may be a major down-
stream target of NSD1 in the nervous system. To test this
hypothesis, we examined the effects of the knockdown of
Nsd1 on the expression of Apc2 using primary mouse cortical
cells. We tested two small hairpin RNA (shRNA) constructss
Figure 6. Impaired Learning Memory Ability
in Apc2-Deficient Mice
(A–F) Impaired learning in Apc2-deficient mice in
the Morris water-maze test.
(A and B) Escape latencies in the visible-platform
task (A) and hidden-platform task (B) were quan-
tified and analyzed.
(C and D) In the probe test, the time spent in each
of the four quadrants (C) and the number of
crossings of the platform position (D) were quan-
tified.
(E) Heatmap representing spatial occupancy in the
probe test. The position of the platform and
boundaries separating the quadrants are shown
by circles and lines, respectively. T, target (the
quadrant in which the platform was constantly
located in the hidden-platform task); L, the quad-
rant left of the target; R, the quadrant right of the
target; O, the quadrant opposite the target.
(F) No significant difference was observed in
swimming speeds in the probe test among
the three genotypes. Apc2+/+ (n = 11), Apc2+/
(n = 12), and Apc2/ (n = 11). Data are the
mean ± SE.
In (B), *p < 0.05, significant difference between
trial-matched Apc2/ and WT mice; #p < 0.05,
significant difference between trial-matched
Apc2+/ and WT mice (ANOVA followed by
Scheffe’s post hoc test). In (D), *p < 0.05, signifi-
cant difference between the indicated pairs
(Tukey-Kramer test).
(G) Impaired learning in Apc2-deficient mice in a
conditioned-fear test. The time spent in the dark
compartment (footshock-receiving side) before
(Pre) and 24 hr after (T1) receiving footshocks was
quantified and analyzed. T2 was the second test.
Apc2+/+ (n = 11), Apc2+/ (n = 11), and Apc2/
(n = 11). Data are the mean ± SE. *p < 0.05, **p <
0.01, significant difference between the indicated
pairs (ANOVA followed by Scheffe’s post hoc test).directed toward different target sites in Nsd1, together with a
control scramble shRNA construct. The expression level of
Nsd1 was reduced by 40% (Figures 7A and 7B). The knock-
down of Nsd1 significantly reduced the expression of Apc2
mRNA to 40% of the control level (Figures 7A and 7B). Under
the same experimental conditions, the expression of ApcCell Reports 10, 1585–1598mRNA, a member of the same gene fam-
ily as Apc2, was not affected at all (Fig-
ures 7A and 7B). Western blot analyses
confirmed that the expression of APC2
was suppressed by the knockdown of
Nsd1: the knockdown of Nsd1 reduced
the expression of the APC2 protein to
50% of the control level (Figure 7C).
These results suggested that Apc2 is a
downstream effector gene of Nsd1.
We tested this possibility via in utero
electroporation of miRNA (Baek et al.,
2014) in order to examine the effects of
Nsd1 knockdown on the migration ofcortical neurons, because Apc2-deficient mice have marked de-
fects in neuronal migration and layering in some brain regions,
including the cerebral cortex (Shintani et al., 2012). When control
scrambled miRNA was introduced into cortical progenitor cells
at embryonic day 15.5 (E15.5), most of the transfected neurons
migrated normally to layer II-IV of the cortex at postnatal day 7, March 10, 2015 ª2015 The Authors 1593
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(P7) (Figure 7D). In contrast, a large population of neurons that
were transfected with Apc2-miRNA remained in the lower layers
(Figure 7D), which is in line with the phenotype observed in the
Apc2/mouse brain (Shintani et al., 2012). Of note, cortical neu-
rons transfected with Nsd1-miRNA showed a similar impairment
in their migration (Figure 7D). In order to confirm that the migra-
tion defect induced by Nsd1 knockdown was attributed to the
downregulated expression ofApc2, we performed rescue exper-
iments. Importantly, co-electroporation of the Nsd1-miRNA
construct with the Apc2-expression plasmid significantly
rescued themigration defect in transfected neurons in the cortex
(Figure 7E). This rescue effect was not observed with a control
plasmid. Taken together, these results indicated that the expres-
sion of NSD1 controlled neuronal migration through the induc-
tion of APC2 expression.
DISCUSSION
In the present study, we identified two siblings who were diag-
nosed with Sotos-like syndrome and presented with intellectual
disability as well as characteristic facial features and a large
head circumference. WES analyses revealed a homozygous sin-
gle-nucleotide duplication in the APC2 gene (c.5199 dup)
in these patients. This duplication resulted in a frameshift
of 418 amino acids followed by a premature stop codon
(p.[Lys1734Glnfs*418]). Expression assays in cultured neuronal
cells showed that the mutated APC2 protein in our patients
was functionally null in its ability to regulate microtubule and
actin dynamics. MRI and CT imaging demonstrated that
Apc2-deficient mice and the male patient had an abnormal brain
structure and head shape. In addition, a series of behavioral tests
revealed that, like our patients, Apc2-deficient mice had
impaired learning and memory abilities. Thus, the phenotypes
observed inApc2-deficientmicemarkedly resembled the clinical
features present in the affected siblings, suggesting that a defi-
ciency in APC2 caused the Sotos features in our patients. The
knockdown of Nsd1 (the main gene responsible for Sotos syn-
drome) in neuronal cells suppressed the expression of theFigure 7. Effects of Nsd1 Knockdown on Apc2 Expression in Cortical N
(A) RT-PCR analyses of the expression of Nsd1, Apc2, and Apc in Nsd1 shRNA
neurons transfected with the indicated shRNA. Two distinct shRNA constructs (
control.
(B) Quantitative real-time RT-PCR analyses of the expression of Nsd-1, Apc2, an
indicated genes were determined by quantitative real-time PCR. Data are norm
shRNA-transfected cells. Data are the mean ± SE (n = 3). **p < 0.01, significantly
post hoc test).
(C) Expression ofNSD1,APC2, and b-tubulin in primary cortical cells transfectedwith
columns: inquantitativeanalyses, signal intensitiesweremeasured, andexpression l
Data are the mean ± SE (n = 3). **p < 0.01, significantly different from control shRNA
(D) Effects of Nsd1 knockdown on the migration of cortical neurons. The control
ventricular region of the forebrain at E15.5 and the location of GFP+ transfected c
100 mm. The diagram shows the quantification of the distribution of GFP+ cells in d
Data are the mean ± SE (n = 5 embryos per group). **p < 0.01, significantly differen
post hoc test).
(E) Rescue of the Nsd1-miRNA-induced migration defect by Apc2 expression. N
into the cerebral cortex at E15.5, and the location of GFP+ cells was assessed at
shows the quantification of the distribution of GFP+ cells in distinct parts of the c
embryos per group). **p < 0.01, significantly different from the cortex electroporate
hoc test).
CellApc2 gene, which led to developmental defects in the brain.
These results strongly indicated that Apc2 is a crucial target
of Nsd1.
Mental Retardation and Overgrowth Syndromes
Overgrowth syndromes are a group of genetic disorders that
involve an abnormal increase in the size of the body or a body
part, and are often detected at birth. Genetic overgrowth syn-
dromes are characterized by a non-hormonally mediated over-
growth condition that accompanies increased height and/or
head circumference, various degrees of mental retardation, or
physical dysmorphisms in children (Ko, 2013). Overlaps in the
phenotypic clinical and molecular genetic features among over-
growth syndromes have been reported, which often makes it
difficult to establish a specific diagnosis. Sotos syndrome, also
known as cerebral gigantism, is a well-known overgrowth syn-
drome that is defined by a characteristic facial appearance and
intellectual disability. The four conditions most commonly
confused with Sotos syndrome are Weaver syndrome, Ban-
nayan-Riley-Ruvalcaba syndrome, Beckwith-Wiedemann syn-
drome, and benign familial macrocephaly (Tatton-Brown and
Rahman, 2013).
Sotos (OMIM #117550) and Weaver (OMIM #277590) syn-
dromes show the greatest phenotypic overlap. The facial fea-
tures of these conditions are similar, particularly in infancy
(Weaver et al., 1974; Cole et al., 1992; Tatton-Brown et al.,
2005). However, these conditions become easier to distinguish
as children get older, because patients with Sotos syndrome
have a long, triangular-shaped face with a prominent chin,
whereas those with Weaver syndrome have a round, coarse
face with a small chin (Allanson et al., 2009). Since the overall
facial appearance of our patients was consistent with that of So-
tos syndrome, they were diagnosed with Sotos-like syndrome.
APC2 as the Gene Responsible for Sotos Features in the
Nervous System
Syndromic intellectual disability represents a heterogeneous
group of genetic disorders with a large number of underlyingeurons and Their Migration during Development
-transfected primary cortical cells. RNAs were prepared from primary cortical
#1 and #2) were used for the knockdown of Nsd1. Gapdh served as a loading
d Apc in shRNA-transfected primary cortical cells. The expression levels of the
alized to Gapdh mRNA and shown as relative values compared with control
different from control shRNA-transfected cells (ANOVA followed by Scheffe’s
the shRNAconstruct. Left: representative imagesofwestern blot analyses. Right
evelsareshownasrelativevaluescomparedwithcontrol shRNA-transfectedcells.
-transfected cells (ANOVA followed by Scheffe’s post hoc test).
miRNA, Apc2-miRNA, or Nsd1-miRNA construct was electroporated into the
ells was assessed at P7. Nuclei were stained with DAPI. Scale bars represent
istinct parts of the cerebral cortex (layer II-IV, layer V-VI, andwhitematter [WM]).
t from the control miRNA-electroporated cortex (ANOVA followed by Scheffe’s
sd1-miRNA was co-electroporated with a control or Apc2-expressing plasmid
P7. Nuclei were stained with DAPI. Scale bars represent 100 mm. The diagram
erebral cortex (layer II-IV, layer V-VI, and WM). Data are the mean ± SE (n = 5
d withNsd1-miRNA and the control vector (ANOVA followed by Scheffe’s post
Reports 10, 1585–1598, March 10, 2015 ª2015 The Authors 1595
genes. Due to this locus heterogeneity, linkage studies have so
far failed to identify many of the genetic causes. The advent of
next-generation sequencing has allowed us to examine small
families with a few affected individuals, particularly in the case
of a recessive mode of inheritance and consanguinity, to effi-
ciently limit the number of candidate genes and follow discov-
eries with functional studies. In many cases, these studies
have provided novel insights into gene functions and their roles
in human development.
Neuronal migration is a critical step in the formation of the ner-
vous system. During development, neurons migrate from their
origin to their final destination, where they form neuronal archi-
tectures that are necessary for information processing in the ner-
vous system, such as laminated structures and nuclei. Failures
or delays in neuronal migration are known to cause a wide range
of disorders, including lissencephaly, schizophrenia, autism, and
mental retardation (Liu, 2011; Wu et al., 2014). Many genes have
been suggested to cause these disorders, and various genes
have been shown to play roles in cytoskeletal regulation,
including the functions of microtubules (LIS1, DCX, TUBA1A,
and TUBB3) and actins (FilaminA) (Gleeson et al., 1998; Jaglin
et al., 2009; Keays et al., 2007; Reiner et al., 1993; Sheen
et al., 2001).
We identified a frameshift mutation in theAPC2 gene in the So-
tos-like siblings by WES. In previous studies, we reported that
Apc2 knockout or knockdown animals had marked defects in
neuronal migration and path finding (Shintani et al., 2009,
2012). Severe layering defects were observed in some brain re-
gions of Apc2-deficient mice, including the cerebral cortex, cer-
ebellum, and hippocampus, and Apc2-knockdown retinal axons
exhibited abnormal projections to the optic tectum. As ex-
pected, Apc2-deficient mice also exhibited impaired learning
and memory abilities (Figures 5 and 6).
Defects in neuronal migration and path finding have been
implicated in commonly observed white matter abnormalities
in the human and mouse brain, including dilated aspects of the
ventricle and agenesis (or hypoplasia) of the corpus callosum,
the major fiber tract connecting the two cerebral hemispheres
(Liu, 2011). Brain MRI images of the male patient revealed ven-
tricular abnormalities (Figure 4A), as previously reported in
some patients with Sotos syndrome (Cecconi et al., 2005;
Schaefer et al., 1997). Agenesis or hypoplasia of the corpus cal-
losum has also occasionally been observed in Sotos syndrome
patients (Cecconi et al., 2005; Schaefer et al., 1997). Dilated ven-
tricles and hypoplasia of the corpus callosum were clearly
observed in the Apc2-deficient mouse brain (Figures 4B and
4C), and appeared to have been caused by defects in the
neuronal migration and axon tract formation of Apc2-deficient
cortical neurons. Furthermore, seizures, which have been re-
ported in some patients with Sotos syndrome, have occasionally
been observed in Apc2-deficient mice (Shintani et al., 2012).
These findings strongly support the notion that APC2 is the
gene responsible for Sotos features in the brain.
Relationship between NSD1 and APC2
Abnormalities in NSD1 cause up to 90% of Sotos syndrome
cases (Baujat and Cormier-Daire, 2007; Douglas et al., 2003;
Kurotaki et al., 2002). NSD1 is a SET-domain-containing histone1596 Cell Reports 10, 1585–1598, March 10, 2015 ª2015 The Authormethyltransferase that plays key roles in the regulation of tran-
scription through histonemodifications and chromatinmodeling.
It preferentially methylates lysine residue 36 of histone 3 (H3K36)
and is primarily associated with active transcription. Histone
methylation has also been implicated in brain development and
functions, as well as in brain disorders (Xu and Andreassi,
2011). However, specific effector genes under the control of
NSD1 have not yet been identified. In the present study, we
demonstrated that Apc2 was regulated by Nsd1 both in vitro
and in vivo. Knockdown of Nsd1 suppressed the expression of
Apc2 in primary cortical neurons, and Nsd1 knockdown in the
embryonic brain caused migration defects in cortical neurons
during development that were rescued by the co-expression of
Apc2. Furthermore, the main features of Sotos syndrome were
faithfully reproduced in patients with a frameshift mutation in
APC2 as well as in Apc2-deficient mice. These results strongly
indicate that the suppressed expression of APC2 in the CNS is
a major event in Sotos syndrome.
Deletions and mutations in the NFIX (nuclear factor I-X) gene,
which encodes a transcriptional regulator, were very recently de-
tected in some patients with Sotos-like features who showed no
abnormalities in the NSD1 gene (Malan et al., 2010; Yoneda
et al., 2012). We knocked down the Nfix gene in mouse neurons
with shRNA, and found that Apc2 expression remained un-
changed (data not shown).
The Apc2-Deficient Mouse Is a Good Model
of Sotos Syndrome
Mousemodels of Sotos syndrome are useful for investigating the
pathogenetic mechanism underlying this syndrome, and for
developing therapeutic approaches. The Nsd1/mouse shows
embryonic lethality due to impairments in gastrulation (Rayasam
et al., 2003). However, the Nsd1+/ mouse did not show clear
phenotypes (Rayasam et al., 2003), in contrast to the patients
with Sotos syndrome caused by haploinsufficiency of NSD1.
This may suggest that the phenotypes were compensated for
by the other NSD family members in mice. On the other hand,
Apc2-deficient mice recapitulated many features of Sotos syn-
drome, as described above. From this point of view, there is a
possibility that APC2 expression is almost suppressed in pa-
tients with Sotos syndrome. Thus, the Apc2-deficient mouse ap-
pears to be a goodmodel of Sotos syndrome, especially with re-
gard to intellectual/learning disabilities and malformation of the
brain.
However, the Apc2-deficient mice and our patients did not
exhibit the other Sotos features occasionally observed in some
Sotos cases, such as hypotonia, advanced bone age, progna-
thia, cardiac and renal anomalies, and scoliosis (Tatton-Brown
et al., 2005), all of which are non-neuronal phenotypes. NSD1
has been proposed to function as a transcriptional regulator for
many genes through the regulation of chromatin (Berdasco
et al., 2009). Moreover, NSD1 is expressed in various tissues be-
sides the brain (Kurotaki et al., 2002), in contrast to APC2,
which is specifically expressed in the nervous system (http://
www.brainspan.org; Shintani et al., 2009, 2012). Therefore,
NSD1 may regulate other genes, the dysregulation of which
causes other Sotos features in other tissues, such as bone and
the heart.s
Our patients had an increased OFC (98th percentile), which is
a key feature of Sotos syndrome. The ratio of skull circumference
to body length was higher in Apc2-deficient mice than in WT
mice. Since APC2 is specifically expressed in postmitotic neu-
rons, the abnormal head structure may be due to a malformation
of the brain. Further functional and mutational analyses are
needed in order to elucidate the relationship between brain
development and head development.
Conclusions
In the present study, we demonstrated that a homozygous loss-
of-function mutation in APC2 caused a number of Sotos fea-
tures. APC2 appears to be the key downstream gene controlled
by NSD1, in which a haploinsufficiency causes Sotos syndrome.
This study explains the pathogenesis of Sotos phenotypes
related to the CNS. Therefore, molecular testing of APC2 needs
to be considered for patients with Sotos features who show no
abnormalities in NSD1 or NFIX. To the best of our knowledge,
neuronal migration defects have not been described in Sotos
syndrome. However, it is difficult to detect migration defects
and abnormal layering in the brain by MRI. Therefore, the post-
mortem brains of patients with Sotos syndrome need to be care-
fully examined. Further functional analyses of NSD1 and APC2
will provide deep insights into the pathogenetic mechanism un-
derlying Sotos syndrome. The main challenge in the future will
be to elucidate the functional roles of APC2 in neural-circuit
formation and synaptic plasticity, which may be more directly
relevant to the intellectual disability in Sotos syndrome. The
Apc2-deficient mouse may be a suitable animal model for
such studies.
EXPERIMENTAL PROCEDURES
Patients and Samples
The patients’ family was recruited for genetic studies through the Genetic
Clinic at the Hamad Medical Corporation (HMC), Doha, Qatar, as part of a
research project funded by the Qatar Foundation with the approval of the insti-
tutional review board at HMC. See the Supplemental Experimental Procedures
for details.
WES Analysis
We performed WES on genomic DNA (3 mg) from each of the two affected in-
dividuals of this family according to our standard protocols at the Genome
Quebec Innovation Center, Montreal, Canada (McDonald-McGinn et al.,
2013). See the Supplemental Experimental Procedures for details.
Mice
Apc2-deficient (Apc2+/) mice have been described previously (Shintani et al.,
2012). Experiments with animals were carried out according to the guidelines
of the National Institute for Basic Biology (Okazaki, Japan). See the Supple-
mental Experimental Procedures for details.
Statistical Analyses
Statistical analyseswere performedwith StatView (version 5.0J; SAS Institute),
SPSS Statistics 20 (IBM), and SigmaPlot (version 12.5; Systat Software). The
results are presented as the mean ± SEM. Significance was set as p < 0.05.
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